179 related articles for article (PubMed ID: 11123762)
21. CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas.
Dogan A; Bagdi E; Munson P; Isaacson PG
Am J Surg Pathol; 2000 Jun; 24(6):846-52. PubMed ID: 10843287
[TBL] [Abstract][Full Text] [Related]
22. Coexpression of Bcl-6 and CD10 in diffuse large B-cell lymphomas: significance of Bcl-6 expression patterns in identifying germinal center B-cell lymphoma.
Ree HJ; Yang WI; Kim CW; Huh J; Lee SS; Cho EY; Ko YH; Charney D
Hum Pathol; 2001 Sep; 32(9):954-62. PubMed ID: 11567225
[TBL] [Abstract][Full Text] [Related]
23. Triple-hit B-cell Lymphoma With MYC, BCL2, and BCL6 Translocations/Rearrangements: Clinicopathologic Features of 11 Cases.
Wang W; Hu S; Lu X; Young KH; Medeiros LJ
Am J Surg Pathol; 2015 Aug; 39(8):1132-9. PubMed ID: 25828391
[TBL] [Abstract][Full Text] [Related]
24. Primary cutaneous B-cell lymphomas in Japan. A report of three cases and a comparison of Japanese and white patients.
Tanaka M; Ichinohasama R; Iwasaki M; Sato M; Tagami H
J Am Acad Dermatol; 1994 Jul; 31(1):54-60. PubMed ID: 8021372
[TBL] [Abstract][Full Text] [Related]
25. CD10 antigen expression correlates with the t(14;18)(q32;q21) major breakpoint region in diffuse large B-cell lymphoma.
Fang JM; Finn WG; Hussong JW; Goolsby CL; Cubbon AR; Variakojis D
Mod Pathol; 1999 Mar; 12(3):295-300. PubMed ID: 10102615
[TBL] [Abstract][Full Text] [Related]
26. IgV(H) and bcl6 somatic mutation analysis reveals the heterogeneity of cutaneous B-cell lymphoma, and indicates the presence of undisclosed local antigens.
Franco R; Camacho FI; Fernández-Vázquez A; Algara P; Rodríguez-Peralto JL; De Rosa G; Piris MA
Mod Pathol; 2004 Jun; 17(6):623-30. PubMed ID: 15098010
[TBL] [Abstract][Full Text] [Related]
27. Composite marginal zone B-cell lymphoma and classical Hodgkin's lymphoma: a clinicopathological study of 12 cases.
Zettl A; Rüdiger T; Marx A; Müller-Hermelink HK; Ott G
Histopathology; 2005 Feb; 46(2):217-28. PubMed ID: 15693895
[TBL] [Abstract][Full Text] [Related]
28. Primary cutaneous marginal zone B-cell lymphoma: a clinical, histopathological, immunophenotypic and molecular genetic study of 22 cases.
Servitje O; Gallardo F; Estrach T; Pujol RM; Blanco A; Fernández-Sevilla A; Pétriz L; Peyrí J; Romagosa V
Br J Dermatol; 2002 Dec; 147(6):1147-58. PubMed ID: 12452864
[TBL] [Abstract][Full Text] [Related]
29. Cutaneous follicular B-cell lymphoma: description of a series of 18 cases.
Franco R; Fernandez-Vazquez A; Rodriguez-Peralto JL; Bellas C; López-Ríos F; Sáez A; Villuendas R; Navarrete M; Fernandez I; Zarco C; Piris MA
Am J Surg Pathol; 2001 Jul; 25(7):875-83. PubMed ID: 11420458
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathologic, immunophenotypic, and molecular characterization of primary cutaneous follicular B-cell lymphoma.
Bergman R; Kurtin PJ; Gibson LE; Hull PR; Kimlinger TK; Schroeter AL
Arch Dermatol; 2001 Apr; 137(4):432-9. PubMed ID: 11295923
[TBL] [Abstract][Full Text] [Related]
31. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
Matolcsy A; Chadburn A; Knowles DM
Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
[TBL] [Abstract][Full Text] [Related]
32. [Analysis of bcl-6 protein expression and gene rearrangement in diffuse large B-cell lymphoma].
Min DL; Xia HL; Zhou XY; Sun MH; Yang WT; Zhang TM; Zheng AH; Shi DR
Zhonghua Bing Li Xue Za Zhi; 2005 Jun; 34(6):327-31. PubMed ID: 16185497
[TBL] [Abstract][Full Text] [Related]
33. Differentiating lymphoblastic lymphoma and Ewing's sarcoma: lymphocyte markers and gene rearrangement.
Ozdemirli M; Fanburg-Smith JC; Hartmann DP; Azumi N; Miettinen M
Mod Pathol; 2001 Nov; 14(11):1175-82. PubMed ID: 11706081
[TBL] [Abstract][Full Text] [Related]
34. Differential diagnosis of cutaneous infiltrates of B lymphocytes with follicular growth pattern.
Leinweber B; Colli C; Chott A; Kerl H; Cerroni L
Am J Dermatopathol; 2004 Feb; 26(1):4-13. PubMed ID: 14726817
[TBL] [Abstract][Full Text] [Related]
35. Primary cutaneous diffuse large B-cell lymphoma (PCDLBCL), leg-type and other: an update on morphology and treatment.
Paulli M; Lucioni M; Maffi A; Croci GA; Nicola M; Berti E
G Ital Dermatol Venereol; 2012 Dec; 147(6):589-602. PubMed ID: 23149705
[TBL] [Abstract][Full Text] [Related]
36. T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells.
Lim MS; Beaty M; Sorbara L; Cheng RZ; Pittaluga S; Raffeld M; Jaffe ES
Am J Surg Pathol; 2002 Nov; 26(11):1458-66. PubMed ID: 12409722
[TBL] [Abstract][Full Text] [Related]
37. bcl-2 protein expression and correlation with the interchromosomal 14;18 translocation in cutaneous lymphomas and pseudolymphomas.
Cerroni L; Volkenandt M; Rieger E; Soyer HP; Kerl H
J Invest Dermatol; 1994 Feb; 102(2):231-5. PubMed ID: 8106752
[TBL] [Abstract][Full Text] [Related]
38. [Survival of patients with primary central nervous system diffuse large B-cell lymphoma: impact of gene aberrations and protein overexpression of bcl-2 and C-MYC, and selection of chemotherapy regimens].
Yin WJ; Zhu X; Yang HY; Sun WY; Wu MJ
Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):32-38. PubMed ID: 29325248
[No Abstract] [Full Text] [Related]
39. [Cutaneous B cell processes with nodular pattern].
Chirife AM; Bilbao ER; Giménez L; Marino L
Medicina (B Aires); 2006; 66(4):307-12. PubMed ID: 16977965
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathologic analysis of CD10+ and CD10- diffuse large B-cell lymphoma. Identification of a high-risk subset with coexpression of CD10 and bcl-2.
Xu Y; McKenna RW; Molberg KH; Kroft SH
Am J Clin Pathol; 2001 Aug; 116(2):183-90. PubMed ID: 11488064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]